Please use this identifier to cite or link to this item:
http://hdl.handle.net/11718/2023
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bhat, Ramesh | |
dc.contributor.author | Maheshwari, Sunil | |
dc.contributor.author | Saha, Somen | |
dc.date.accessioned | 2010-04-08T04:34:50Z | |
dc.date.available | 2010-04-08T04:34:50Z | |
dc.date.copyright | 2004-06-03 | |
dc.date.issued | 2010-04-08T04:34:50Z | |
dc.identifier.uri | http://hdl.handle.net/11718/2023 | |
dc.description.abstract | India stands at a critical junction of HIV pandemic. Controlling spread of HIV is critical. Ignoring this will lead millions of Indians in grip of this pandemic. Ever since HIV/AIDS was acknowledged as a problem, the strategies to address the issue have focused on prevention, treatment and research. This paper discusses the treatment aspect. With currently available antiretroviral agents, eradication of HIV infection is not likely. The aim of treatment is thus to prolong and improve the quality of life by maintaining maximal suppression of virus replication for as long as possible. Brazil has shown how to implement antiretroviral therapy programme. India has embarked upon an ambitious programme to introduce antiretroviral therapy in six high prevalent states and the national capital. The paper discusses the technical, management and financing challenge in implementing this intervention. | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | WP;2004/1822 | |
dc.subject | HIV and AIDS | en |
dc.subject | Antiretroviral therapy | en |
dc.subject | NACO | en |
dc.subject | State AIDS control societies | en |
dc.title | Treating HIV/ AIDS patients in India with antiretroviral therapy: a management challenge | en |
dc.type | Working Paper | en |
Appears in Collections: | Working Papers |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2004-06-03rbhat.pdf | 250.01 kB | Adobe PDF | View/Open |
Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.